Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on the day's biggest business stories
Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Sign up for Axios NW Arkansas
Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters
Illustration: Eniola Odetunde/Axios
Companies are preparing to design digital immunity certificates for COVID-19 that could be used when a vaccine is available.
Why it matters: The vaccine won't roll out to everyone at the same time, so we need some way for those who have been immunized to easily demonstrate that they can safely return to work and travel. The easiest way might be a digital certificate that can be linked to a passport or even a mobile phone.
Background: The World Health Organization already issues paper "yellow cards" that act as an international certification of vaccination, primarily to be used when entering a country that has enhanced health risks to travelers.
- But a paper certificate, as experts warned in a white paper released earlier this year, could be subject to fraud and would be too difficult to quickly scale up for hundreds of millions of people.
- Digital certificates, though, could be rapidly and safely distributed and made easily verifiable at borders or even in businesses, says Lars Reger, the CTO of the semiconductor company NXP, which makes biometric technology now used in some passports.
How it works: Digital certificates could be added onto biometric passports or other smart ID cards that already contain a small chip that is used to confirm the identity of the holder.
- Another option would be to make use of the contactless payment system currently available in most recent smartphones, which could "easily transport the information that someone has certified immunity," says Reger.
- Rolling out such a functionality to smartphones would eliminate the need for investing in new technology, and any business that can read contactless payments should be able to accept immunity certificates with just a software update, he says.
The catch: Some critics worry digital immunity certificates could cause discrimination between those who can show immunity and those who can't.
- We also have to be sure those who receive such certificates really are immune, an immunological uncertainty that torpedoed earlier plans to issue certificates to those who had contracted the disease.
The bottom line: The real challenge around digital immunity certificates isn't the relatively easy technology, but the hard ethical challenges around ensuring everyone ultimately has access to a workable vaccine.
Go deeper: The coming coronavirus vaccine chaos